Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention.
Wake Forest School of Medicine, Winston-Salem, USA.
Joseph
J
Yeboah
D050197:Atherosclerosis / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D008297:Male; D019057:Quality-Adjusted Life Years
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors